Search For "final approval"
Corbevax heterologous COVID-19 booster expected to get final approval from
Updated : 3 years, 7 months ago IST
New Delhi [India], August 9 (ANI): The Union Government is considering giving its final approval to Corbevax's heterologous COVID-19 booster for 'Restricted Use in Emergency Situation' soon, sources said.
Read More
Glenmark Pharmaceuticals receives sANDA approval for Abiraterone Acetate T
Updated : 3 years, 9 months ago IST
Mumbai (Maharashtra) [India], May 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has received final approval by the United States Food & Drug Administration (US FDA) for Abiraterone Acetate Tablets USP, 500 mg, the generic version of Zytiga®1 Tablets, 500 mg, of J
Read More
Glenmark Pharmaceuticals receives ANDA approval for Lacosamide Tablets USP
Updated : 3 years, 11 months ago IST
Mumbai (Maharashtra) [India], March 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Inc., USA (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for its Lacosamide Tablets1 USP, 50 mg, 100 mg, 150 mg and 200 mg, the generic version of Vimpat&
Read More
Zydus receives final approval from USFDA to market Colestipol Hydrochlorid
Updated : 4 years ago IST
Ahmedabad (Gujarat) [India], March 15 (ANI): Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market Colestipol Hydrochloride Tablets in the strength of 1mg (US RLD: Colestid), said the pharmaceutical company on Monday.
Read More
Zydus receives final approval from USFDA to market drug used to relieve ch
Updated : 4 years ago IST
New Delhi [India], March 9 (ANI): Zydus Lifesciences Ltd. has received final approval from the United States Food and Drug Administration (USFDA) to market Nitroglycerin Sublingual tablets used to relieve chest pain in people who have certain heart conditions, said the pharmaceutical company
Read More
DCGI gives emergency use authorisation to COVID-19 vaccine Corbevax for 12
Updated : 4 years ago IST
New Delhi [India], February 21 (ANI): Hyderabad-based pharmaceutical company Biological E on Monday received emergency use authorisation from Drugs Controller General of India (DCGI) for its COVID-19 vaccine Corbevax for the 12 to 18 age group.
Read More
Zydus Cadila receives final approval from USFDA for Glycopyrrolate injecti
Updated : 4 years, 4 months ago IST
Ahmedabad (Gujarat) [India], November 10 (ANI): India-based pharma giant, Zydus Cadila received final approval from USFDA for Glycopyrrolate injection that is used before surgery to decrease the volume of secretions from the mouth, lungs and stomach.
Read More
Covaxin for Children will take some more time for final approval: Sources
Updated : 4 years, 4 months ago IST
New Delhi [India], November 8 (ANI): The data for Bharat Biotech's Covaxin for Children, COVID-19 vaccine, is under evaluation and the process will take some more time for final approval from the Drugs Controller General of India (DCGI), sources said.
Read More
Covaxin's approval for children aged 2-18 yrs under experts' opinion, eval
Updated : 4 years, 5 months ago IST
New Delhi [India], October 14 (ANI): The final approval for Bharat Biotech's Covaxin for children aged 2-18 years is under experts opinion and evaluation, stated Government sources on Thursday.
Read More
Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate
Updated : 4 years, 5 months ago IST
Mumbai (Maharashtra) [India], September 21 (ANI/PR Newswire): Glenmark Pharmaceuticals Ltd. (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, the generic version of Evoclin®1 Foam, 1%, of Mylan Pharm
Read More
Glenmark Pharmaceuticals receives ANDA approval for Arformoterol Tartrate
Updated : 4 years, 8 months ago IST
Mumbai (Maharashtra) [India], June 23 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials, the generic version of BROVA
Read More
Glenmark Pharmaceuticals receives ANDA approval for Theophylline Extended-
Updated : 4 years, 9 months ago IST
Mumbai (Maharashtra) [India], June 4 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd (Glenmark) has received final approval by the United States Food & Drug Administration (U.S. FDA) for Theophylline Extended-release Tablets, 300 mg and 450 mg, bioequivalent and therapeutically equivalent
Read More